Investigation of cyclooxygenase and signaling pathways involved in human platelet aggregation mediated by synergistic interaction of various agonists

about

The increased level of COX-dependent arachidonic acid metabolism in blood platelets from secondary progressive multiple sclerosis patients.

P2860

Q37191533-43936EC2-6BA2-4764-AC0A-500DC6F9FFA1

P2860

Investigation of cyclooxygenase and signaling pathways involved in human platelet aggregation mediated by synergistic interaction of various agonists

Item

http://www.wikidata.org/entity/Q40725564

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Investigation of cyclooxygenas ...... nteraction of various agonists

@en

type

Item

label

Investigation of cyclooxygenas ...... nteraction of various agonists

@en

prefLabel

Investigation of cyclooxygenas ...... nteraction of various agonists

@en

P1476

Investigation of cyclooxygenas ...... nteraction of various agonists

@en

P2093

Ahsana Dar Farooq

http://www.w3.org/2001/XMLSchema#string

Bassem Sadek

http://www.w3.org/2001/XMLSchema#string

Nadia Khan

http://www.w3.org/2001/XMLSchema#string

P2860

Arachidonic acid as a bioactive molecule

Requirement for integration of signals from two distinct phosphorylation pathways for activation of MAP kinase.

Intracoronary ketanserin augments coronary collateral blood flow and decreases myocardial ischemia during balloon angioplasty.

PGE(2) -EP(2) signalling in endothelium is activated by haemodynamic stress and induces cerebral aneurysm through an amplifying loop via NF-κB.

Evidence of more ion channels inhibited by celecoxib: KV1.3 and L-type Ca(2+) channels

PGI2 as a regulator of inflammatory diseases.

Activation of platelet function through G protein-coupled receptors.

Platelet receptors and signaling in the dynamics of thrombus formation.

Differential effects of selective cyclooxygenase-2 inhibitors on vascular smooth muscle ion channels may account for differences in cardiovascular risk profiles.

Platelet biology and receptor pathways.

P304

3497-3506

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/DDDT.S84335

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-07-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

281690368

http://www.w3.org/2001/XMLSchema#string

P698

26185418

http://www.w3.org/2001/XMLSchema#string

P932

4500629

http://www.w3.org/2001/XMLSchema#string

Investigation of cyclooxygenase and signaling pathways involved in human platelet aggregation mediated by synergistic interaction of various agonists

about

P2860

P2860

Investigation of cyclooxygenase and signaling pathways involved in human platelet aggregation mediated by synergistic interaction of various agonists

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P5875

P698

P932